Article info
Neurological rarities
Primary progressive aphasia: ReADing the clinical GRANularity
- Correspondence to Dr Jason D Warren, Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK; jason.warren{at}ucl.ac.uk
Citation
Primary progressive aphasia: ReADing the clinical GRANularity
Publication history
- Accepted May 21, 2022
- First published June 16, 2022.
Online issue publication
October 18, 2023
Article Versions
- Previous version (30 November 2022).
- Previous version (30 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications
- Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review
- Frontotemporal dementia
- Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias
- Clinical comparison of progressive aphasia associated with Alzheimer versus FTD-spectrum pathology
- Speech and language therapy approaches to managing primary progressive aphasia
- Plasma tau is increased in frontotemporal dementia
- Logopenic aphasia in Alzheimer's disease: clinical variant or clinical feature?
- Biomarkers in dementia: clinical utility and new directions
- Clinicoradiological and neuropathological evaluation of primary progressive aphasia